Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DuP 785

Known as: DUP-785, DUP785 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The mechanism of action of NSC 368390 (DUP-785, 6-fluoro-2-(2′-fluoro-1, 1′-biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1993
1993
Current maintenance immunosuppressive therapy consists of cyclosporine in combination with prednisone and azathioprine… Expand
1992
1992
Brequinar sodium (DUP-785; Brequinar) is a potent inhibitor of the pyrimidine de novo enzyme dihydroorotate dehydrogenase (DHO-DH… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table I
Highly Cited
1990
Highly Cited
1990
Little is known about the in vivo effects of inhibition of the mitochondrial pyrimidine de novo synthesis enzyme dihydroorotic… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
1990
1990
Brequinar sodium (DUP-785) is a potent inhibitor of the pyrimidine de novo enzyme, dihydroorotic acid dehydrogenase (DHO-DH). In… Expand
1990
1990
The effect of Brequinar sodium on the growth of xenografts established from head and neck squamous cell carcinomas (HNSCC) was… Expand
1989
1989
DUP-785, a new inhibitor of dihydroorotate dehydrogenase, is currently undergoing clinical evaluation for anticancer activity. We… Expand
Highly Cited
1985
Highly Cited
1985
A novel, substituted 4-quinolinecarboxylic acid (NSC 339768) demonstrated antitumor activity against L1210 leukemia and B16… Expand